LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 82 filers reported holding LION BIOTECHNOLOGIES INC in Q1 2017. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,713,000 | -17.8% | 230,000 | -23.3% | 0.85% | -30.6% |
| Q4 2016 | $2,085,000 | -9.5% | 300,000 | +7.1% | 1.23% | +1.9% |
| Q3 2016 | $2,304,000 | +9.4% | 280,000 | +7.7% | 1.21% | -14.3% |
| Q2 2016 | $2,106,000 | -13.0% | 260,000 | +30.0% | 1.41% | +25.2% |
| Q1 2015 | $2,422,000 | – | 200,000 | – | 1.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,188,331 | $15,209,000 | 19.14% |
| ACUTA CAPITAL PARTNERS, LLC | 3,809,944 | $26,479,000 | 9.85% |
| Avoro Capital Advisors LLC | 4,520,643 | $31,418,000 | 6.35% |
| Broadfin Capital, LLC | 2,638,259 | $18,336,000 | 2.04% |
| Perceptive Advisors | 3,567,553 | $24,794,000 | 1.76% |
| Ghost Tree Capital, LLC | 975,000 | $6,776,000 | 1.63% |
| Opaleye Management Inc. | 300,000 | $2,085,000 | 1.23% |
| Rhenman & Partners Asset Management AB | 650,000 | $4,518,000 | 0.87% |
| ACUTA CAPITAL PARTNERS, LLC | 150,000 | $1,043,000 | 0.39% |
| QVT Financial LP | 1,498,809 | $10,349,000 | 0.31% |